Skip to content
Hemp Law Watch
Back to Maine
No active alertUpdateMaine

Maine warns medical cannabis patients about contaminated flower and pre-rolls, and says it has no recall power in the medical program

Tests found unsafe levels of bacteria, yeast and mold in products from The B Maine in Lebanon, the Office of Cannabis Policy said Oct. 14. Because state law gives it no recall authority over medical cannabis, the office issued a patient advisory instead of a recall notice.

Hemp Law Watch desk2 min readState jurisdictionLog in to save

Authorship warning

One or more sources supporting this report could not be confirmed as the work of a credited author or an identifiable official body. The signals behind that assessment are listed with each source citation below.

Maine's Office of Cannabis Policy (OCP) issued a Medical Cannabis Patient Advisory on Oct. 14, 2026, for medical cannabis flower and pre-rolls produced and sold by The B Maine, formerly known as Dr. Melo's, in the town of Lebanon. WGME reported the advisory on Oct. 15.

According to OCP, the office received a complaint in mid-September about conditions at the company's cultivation facility. Its investigation included testing "Florida Oranges" flower grown there, and the results showed unsafe levels of microbial contaminants (aerobic bacteria, coliforms and Enterobacteriaceae), yeast and mold. OCP then tested additional products and found varying unsafe levels of the same contaminants in two strains of flower, "Florida Oranges" and "Skunk Hero," and four strains of 1-gram pre-rolls: "Bad Apple," "Cherry AK," "Head Candy" and "Tropsicles." OCP said the samples would have failed the testing standards used in Maine's adult-use program.

The advisory also points to a gap in the rules. OCP said it does not have authority under Maine law to issue a recall in the Maine Medical Use of Cannabis Program, unlike its recall authority in the Adult Use Cannabis Program, and that the medical program is not subject to the same mandatory inventory tracking or contaminant testing requirements. None of The B Maine's products were required to be tested for contaminants, and none had been, the office said. OCP said that limits how much information and detail it can provide compared with its adult-use recall notices.

According to OCP, The B Maine expressed a willingness to protect patient safety and voluntarily surrendered the contaminated products to the office for destruction. The advisory lists possible symptoms from inhaling contaminated cannabis and tells patients who have symptoms to contact a healthcare provider.

Source citation cards

Authorship is reported as a signal for editorial review. Automated checks cannot prove who wrote a document, so every card records what was found and what remains uncertain.

Source 1Source not retrievable

Maine Office of Cannabis Policy Issues Medical Cannabis Patient Advisory for Cannabis Flower and Pre-rolls Produced and Sold by The B Maine

Publisher
Maine Office of Cannabis Policy (Department of Administrative and Financial Services)
Author
No byline credited
Published
Oct 14, 2026
Jurisdiction
ME
Severity
No active alert
Retrieval
HTTP 403
Official bodyOpen source

Authorship signal — The content is hosted on a government domain associated with the Maine Office of Cannabis Policy.

Warning: Source returned HTTP 403.

Source 2Source verified

State warns of contaminated medical marijuana from Lebanon

Publisher
WGME
Author
WGME Staff
Published
Oct 15, 2026
Jurisdiction
ME
Severity
No active alert
Retrieval
HTTP 200
Credited authorOpen source

Authorship signal — The article credits WGME Staff, suggesting journalistic output from a news organization.

Source 3Source not retrievable

Medical Cannabis Patient Advisory - The B Maine Flower & Pre-rolls - 10/14/2026

Publisher
Maine Office of Cannabis Policy (Department of Administrative and Financial Services)
Author
No byline credited
Published
Oct 14, 2026
Jurisdiction
ME
Severity
No active alert
Retrieval
HTTP 403
Official bodyOpen source

Authorship signal — The URL structure and domain indicate this is intended to be a government regulatory advisory.

Warning: Source returned HTTP 403.

Discussion

0 comments

Log in to join the discussion. Comments are public and appear with your name.

No comments yet. Be the first to add context.

Hemp Law Watch

A nationwide publication tracking hemp and cannabis law as it changes. Every published report carries its sources, authorship signals and an alert classification.

Sections

Editorial

Alert classifications

  • Federal alert
  • Misdemeanor / ticketable

Hemp Law Watch reports on legal developments and does not provide legal advice. State summaries are editorial reference points reviewed by the desk; always confirm against the cited primary sources.

© 2026 Hemp Law Watch